Recent studies have demonstrated that apoA-I glycation decreases its stability and results in a threefold shorter half-life of apoA-I, leading to the generation of dysfunctional HDL in type 2 diabetes [46]. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.